Fig. 3
- ID
- ZDB-FIG-240703-68
- Publication
- Choleva et al., 2024 - Targeting the interaction of pleiotrophin and VEGFA165 with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesis
- Other Figures
- All Figure Page
- Back to All Figure Page
PTN97–110 inhibits chick embryo CAM angiogenesis. Different amounts of the peptide were applied to the CAM and 48 h later, the total vessel length was estimated using image analysis software. Results are expressed as the percent change of the total vessel length in PTN97-110-treated compared with the vehicle (PBS)-treated CAMs (control) from at least four independent experiments. The box plots indicate the median, mean, and range of each group. Asterisks denote a statistically significant difference from the control. ***P < 0.001, ****P < 0.0001. The pictures are representative of the vessel network of the chicken embryo CAM. |
Reprinted from European Journal of Pharmacology, 977, Choleva, E., Menounou, L., Ntenekou, D., Kastana, P., Tzoupis, Η., Katraki-Pavlou, S., Drakopoulou, M., Spyropoulos, D., Andrikopoulou, A., Kanellopoulou, V., Enake, M.K., Beis, D., Papadimitriou, E., Targeting the interaction of pleiotrophin and VEGFA165 with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesis, 176692, Copyright (2024) with permission from Elsevier. Full text @ Eur. J. Pharmacol.